TrialESMO open2025

Efficacy, safety, and pharmacokinetics of eribulin as monotherapy or in combination with irinotecan for patients with pediatric rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcoma, or Ewing sarcoma.

M Casanova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.